San Diego, CA, United States of America

Gregory Jay Haley

This inventor holds 14 USPTO granted patents and 1 published patent application. Top assignees: Anadys Pharmaceuticals, Inc., Hoffmann-La Roche Inc.. Active years: 2008-2016.

USPTO Granted Patents = 14 

% Patents Active = 21.4

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 145(Granted Patents)


Location History:

  • Del Mar, CA (US) (2009 - 2012)
  • San Diego, CA (US) (2008 - 2016)

Company Filing History:


Years Active: 2008-2016

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Gregory Jay Haley: Innovator in Pharmaceutical Compounds

Introduction

Gregory Jay Haley is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work primarily focuses on the development of compounds that have therapeutic applications.

Latest Patents

One of his latest patents is a method of preparing deoxyribofuranose compounds. This invention relates to methods for making deoxyribofuranose compounds, which are useful intermediates in the preparation of pharmaceutical compounds. Another notable patent involves 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds. This invention is directed towards compounds that exhibit immunomodulatory activity and outlines their therapeutic or prophylactic use.

Career Highlights

Throughout his career, Gregory has worked with notable companies such as Anadys Pharmaceuticals, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Gregory has collaborated with several professionals in his field, including Stephen Evan Webber and Binh Vu. These collaborations have likely enhanced his research and development efforts.

Conclusion

Gregory Jay Haley is a distinguished inventor whose work in pharmaceutical compounds has led to numerous patents and advancements in the field. His contributions continue to impact the development of therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…